Cargando…

The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy

Erythropoietin (EPO), a hematopoietic neurotrophin, is a potential therapeutic for Alzheimer’s disease (AD) but has limited blood–brain barrier (BBB) permeability. EPO fused to a chimeric transferrin receptor monoclonal antibody (cTfRMAb) enters the brain via TfR-mediated transcytosis across the BBB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Joshua, Ou, Weijun, Jagadeesan, Nataraj, Simanauskaite, Juste, Sun, Jiahong, Castellanos, Demi, Cribbs, David H., Sumbria, Rachita K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141171/ https://www.ncbi.nlm.nih.gov/pubmed/37111315 http://dx.doi.org/10.3390/ph16040558

Ejemplares similares

Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy
por: Ou, Weijun, et al.
Publicado: (2021)

Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 Mice
por: Ou, Weijun, et al.
Publicado: (2022)

Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice
por: Sun, Jiahong, et al.
Publicado: (2019)

Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
por: Castellanos, Demi M., et al.
Publicado: (2020)

Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease
por: Sumbria, Rachita K.
Publicado: (2020)

Comparative studies between the murine immortalized brain endothelial cell line (bEnd.3) and induced pluripotent stem cell-derived human brain endothelial cells for paracellular transport
por: Sun, Jiahong, et al.
Publicado: (2022)

Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy
por: Choi, Yun-Beom, et al.
Publicado: (2021)

The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
por: Yang, Joshua, et al.
Publicado: (2021)

Erythrocyte–brain endothelial interactions induce microglial responses and cerebral microhemorrhages in vivo
por: Zhang, Hai, et al.
Publicado: (2023)

Aging exacerbates development of cerebral microbleeds in a mouse model
por: Sumbria, Rachita K., et al.
Publicado: (2018)

Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy
por: Blair, Laura J, et al.
Publicado: (2015)

Effects of Dabigatran in Mouse Models of Aging and Cerebral Amyloid Angiopathy
por: Michael, Neethu, et al.
Publicado: (2019)

Effects of Deferasirox in Alzheimer’s Disease and Tauopathy Animal Models
por: Kwan, Ping, et al.
Publicado: (2022)

Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
por: Makani, Vishruti, et al.
Publicado: (2016)

Insights Into the Mechanisms of Brain Endothelial Erythrophagocytosis
por: Sun, Jiahong, et al.
Publicado: (2021)

Transmission and spreading of tauopathy in transgenic mouse brain
por: Clavaguera, Florence, et al.
Publicado: (2009)

Erythropoietin dampens injury-induced microglial motility
por: Mitkovski, Miso, et al.
Publicado: (2015)

Tumor necrosis factor α Inhibition for Alzheimer’s Disease
por: Chang, Rudy, et al.
Publicado: (2017)

Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages
por: Sumbria, Rachita K., et al.
Publicado: (2017)

A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
por: Zhang, Bin, et al.
Publicado: (2018)

Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies
por: Majerova, Petra, et al.
Publicado: (2019)

Novel autoimmune response in a tauopathy mouse model
por: Nogueras-Ortiz, Carlos J., et al.
Publicado: (2014)

Using mass spectrometry to validate mouse models of tauopathy
por: Yan, Yan, et al.
Publicado: (2023)

Outcome of repeat penetrating keratoplasty in eyes with failed penetrating keratoplasty
por: Khairallah, Abdulrahman S.
Publicado: (2016)

Chronic kidney disease promotes cerebral microhemorrhage formation
por: Fang, Chuo, et al.
Publicado: (2023)

Astrocytes in Tauopathies
por: Reid, Matthew J., et al.
Publicado: (2020)

Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
por: Garwood, Claire J., et al.
Publicado: (2010)

Analysis of in vivo turnover of tau in a mouse model of tauopathy
por: Yamada, Kaoru, et al.
Publicado: (2015)

Early alterations of neurovascular unit in the retina in mouse models of tauopathy
por: Xia, Fan, et al.
Publicado: (2021)

Plasticity in visual cortex is disrupted in a mouse model of tauopathy
por: Papanikolaou, Amalia, et al.
Publicado: (2022)

Alcohol as a Modifiable Risk Factor for Alzheimer’s Disease—Evidence from Experimental Studies
por: Chandrashekar, Devaraj V., et al.
Publicado: (2023)

Transcriptomic profiling of trichloroethylene exposure in male mouse liver
por: Jiang, Yan, et al.
Publicado: (2015)

High-Altitude Hypoxia Decreases Plasma Erythropoietin Soluble Receptor Concentration in Lowlanders
por: Vizcardo-Galindo, Gustavo, et al.
Publicado: (2020)

Neuroprotective activity of a new erythropoietin formulation with increased penetration in the central nervous system
por: Etcheverrigaray, Marina, et al.
Publicado: (2011)

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
por: Sahara, Naruhiko, et al.
Publicado: (2023)

Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
por: Schaeffer, Véronique, et al.
Publicado: (2012)

Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator
por: Chatterjee, Snehajyoti, et al.
Publicado: (2018)

Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model
por: Shi, Yang, et al.
Publicado: (2019)

Early Cognitive and Behavioral Deficits in Mouse Models for Tauopathy and Alzheimer’s Disease
por: Samaey, Celine, et al.
Publicado: (2019)

Epigenetic treatment of behavioral and physiological deficits in a tauopathy mouse model
por: Wang, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qjff1gip0259q6282p7n0ntl0b